An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021959
Company: CONCORDIA PHARMS INC

Products on NDA 021959

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ORAPRED ODT	PREDNISOLONE SODIUM PHOSPHATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING;ORAL	Prescription	None	Yes	No
ORAPRED ODT	PREDNISOLONE SODIUM PHOSPHATE	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING;ORAL	Prescription	None	Yes	No
ORAPRED ODT	PREDNISOLONE SODIUM PHOSPHATE	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING;ORAL	Prescription	None	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021959

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/01/2006	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021959lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021959TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/06/2020	SUPPL-11	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021959s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021959Orig1s011ltr.pdf
07/28/2016	SUPPL-9	Manufacturing (CMC)		Label is not available on this site.
04/08/2016	SUPPL-8	Manufacturing (CMC)		Label is not available on this site.
07/28/2010	SUPPL-4	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021959s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021959s004ltr.pdf
04/27/2009	SUPPL-3	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021959s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021959s003ltr.pdf

Labels for NDA 021959

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/06/2020	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021959s001lbl.pdf
07/28/2010	SUPPL-4	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021959s004lbl.pdf
04/27/2009	SUPPL-3	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021959s003lbl.pdf
04/27/2009	SUPPL-3	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021959s003lbl.pdf
06/01/2006	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021959lbl.pdf

Top